TransMedics Group Inc (NAS:TMDX)
$ 83 -1.97 (-2.32%) Market Cap: 2.79 Bil Enterprise Value: 3.04 Bil PE Ratio: 88.30 PB Ratio: 13.26 GF Score: 76/100

Transmedics Group Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 10:20PM GMT
Release Date Price: $17.98 (-2.81%)
K. Gong
JPMorgan Chase & Co, Research Division - Analyst

Okay. I'd just like to welcome everyone to the final session of the day here, Wednesday, at the JPMorgan Healthcare Conference. My name is Allen Gong. I'm a member of the medical supplies and devices here at JPMorgan. And it's my pleasure today to have some of the members of the TransMedics management team here on the call, with the CEO, Waleed Hassanein; CFO, Stephen Gordon; and CCO, Tamer Khayal.

(Operator Instructions). And I will be happy to ask any questions that come in right now or during the course of the prepared remarks.

With that, I'll turn it over for -- to the team for any prepared remarks that they have.

Waleed H. Hassanein
TransMedics Group, Inc. - Founder, MD, CEO, President & Director

Thank you, Allen. Good evening, everybody. I'm Waleed Hassanein, CEO of TransMedics. It's a privilege to be here and talking to you about TransMedics.

Slide 2 shows our forward-looking statement. Let's jump in on Slide 3. For you who don't know who TransMedics is and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot